2024-10-23 04:59:19
ASCO 2022 | Ascentage Pharma Releases Updated Results Demonstrating the Therapeutic Potential of Alrizomadlin (APG-115) plus Pembrolizumab in Patients with Solid Tumors who Progressed on Immunotherapies
Corporate/ 2023-07-24
ASCO 2022 | Ascentage Pharma Releases Up...

SUZHOU,China,and ROCKVILLE,Md.,June 7,2022-- scentage Pharma (6855.HK),a global biopharmaceutical company engaged in developing novel therap...

Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule ATR Inhibitor ATG-018
Corporate/ 2023-07-24
Antengene Announces HREC Approval in Aus...

– Discovered in-house bythe internal R&D Team atAntengene,ATG-018 is an orally-bioavailable,small molecule ataxia telangiectasia and Ra...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release